In early October, 18 journalists from 11 African countries converged in Kampala, Uganda for DNDi’s first-ever training on health and science journalism. The three-day training was conducted during a week of workshops and meetings related to the work of DNDi and its many partners, culminating in the 11th DNDi Partners’ Meeting on 4 October 2018.
Ghana Web [11 October 2018]
“Pediatric HIV victims get attention”
Daily Monitor [10 October 2018]
“HIV-positive children to take soluble ARVs”
New Business Ethiopia [3 October 2018]
“New clinical trials for neglected diseases in eastern Africa in progress”
24-27 October 2018
Johannesburg, South Africa
- Carol Ruffel, Head of DNDi South Africa Office – session on infant HIV testing
Daily Nation [26 June 2018]
“Child-friendly antiretrovirals in the pipeline”
24 May 2018
DNDi and MMV, supported by Unitaid, delivered a statement on the progress made by WHO in developing a Global Framework on Nurturing Care for Early Childhood Development. The statement calls for R&D and access to child-friendly medicines, and open data sharing of research findings.
3-4 October 2018
- François Bompart, Director of Paediatric HIV/HCV Programmes, Isabelle Andrieux-Meyer, Head of Clinical Development Paediatric HIV/HCV Programmes, Jean-René Kiechel,Expert in R&D – panel discussion on DNDi‘s journey so far working on Paediatric HIV
- Olawale Salami, Paediatric HIV Clinical Project Manager – panel discussion on access to child-adapted ARV formulations
23-27 July 2018
Amsterdam, the Netherlands
Side event on ending paediatric HIV, presentation on the LIVING study on paediatric HIV, two panel discussions, and poster discussion on TB/HIV co-treatment, and poster on caregiver adherence to oral lopinavir/ritonavir pellets to treat children.
Also: pre-conference workshop session on viral suppression in children taking oral LPV/r
The East African [11 April 2018]
“Uganda leads study for new HIV drug for children”
29 May-1 June 2018
DNDi – poster presentation on TB/HIV paediatric co-treatment
24-25 May 2018
Olawale Salami, Paediatric HIV Clinical Project Manager DNDi Africa – poster about the LIVING study on treatment for paediatric HIV
7th Edition: Precision Global Health in the Digital Age
10-12 April 2018
Bernard Pécoul, Executive Director – plenary talk on emerging infectious diseases crisis
Digas Ngolo, Investigator Coordinator, DNDi Africa – parallel session on ehealth
27 January 2018
Medicines for Malaria Venture and DNDi delivered a joint statement at WHO’s Executive Board 142, urging WHO to recognize the urgent need for research and development, access, and uptake of child-friendly medicines.
4-7 March 2018
DNDi – posters on Paediatric HIV treatments and on drugs interactions in HCV+/-HIV infected adults
14-16 February 2018
Olawale Salami, Paediatric HIV Clinical Project Manager DNDi Africa – presentation of the results of a prospective study on Paediatric HIV.
Monique Wasunna, Director DNDi Africa, and Olawale Salami, Paediatric HIV Clinical Project Manager DNDi Africa – symposium on fighting for neglected patients.
Le Monde [27 November, 2017]
“En Afrique, environ la moitié des séropositifs sont sous traitement” – “In Africa, about half of HIV-positive individuals are treated”
Le Monde [27 November, 2017]
“Les enfants, derniers bénéficiaires de l’innovation médicale” – “Children, the last beneficiaries of medical innovation”
A l’occasion de l’Evénement économique 2017 du 9 novembre dernier, la Chambre de commerce, d’industrie et des services de Genève (CCIG), le Département de la sécurité et de l’économie (DSE) et l’Office de Promotion des Industries et des Technologies (OPI) ont décerné le Prix 2017 de l’innovation à l’initiative Médicaments contre les Maladies Négligées (DNDi).